These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Comparison of contrast agents with high molarity and with weak protein binding in cerebral perfusion imaging at 3 T. Thilmann O; Larsson EM; Björkman-Burtscher IM; Ståhlberg F; Wirestam R J Magn Reson Imaging; 2005 Nov; 22(5):597-604. PubMed ID: 16200539 [TBL] [Abstract][Full Text] [Related]
10. Hemodynamic segmentation of MR brain perfusion images using independent component analysis, thresholding, and Bayesian estimation. Kao YH; Guo WY; Wu YT; Liu KC; Chai WY; Lin CY; Hwang YS; Jy-Kang Liou A; Wu HM; Cheng HC; Yeh TC; Hsieh JC; Mu Huo Teng M Magn Reson Med; 2003 May; 49(5):885-94. PubMed ID: 12704771 [TBL] [Abstract][Full Text] [Related]
11. Dynamic susceptibility contrast perfusion magnetic resonance imaging in patients with symptomatic unilateral middle cerebral artery stenosis or occlusion. Lu J; Li K; Zhang M; Jiao L Acta Radiol; 2007 Apr; 48(3):335-40. PubMed ID: 17453507 [TBL] [Abstract][Full Text] [Related]
12. Partial-volume model for determining white matter and gray matter cerebral blood volume for analysis of gliomas. Lee MC; Cha S; Chang SM; Nelson SJ J Magn Reson Imaging; 2006 Mar; 23(3):257-66. PubMed ID: 16456821 [TBL] [Abstract][Full Text] [Related]
13. Assessment of cerebral hemodynamics and oxygen extraction using dynamic susceptibility contrast and spin echo blood oxygenation level-dependent magnetic resonance imaging: applications to carotid stenosis patients. Kavec M; Usenius JP; Tuunanen PI; Rissanen A; Kauppinen RA Neuroimage; 2004 May; 22(1):258-67. PubMed ID: 15110016 [TBL] [Abstract][Full Text] [Related]
14. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI. Fayed N; Dávila J; Medrano J; Olmos S Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889 [TBL] [Abstract][Full Text] [Related]
15. FAIR and dynamic susceptibility contrast-enhanced perfusion imaging in healthy subjects and stroke patients. Hunsche S; Sauner D; Schreiber WG; Oelkers P; Stoeter P J Magn Reson Imaging; 2002 Aug; 16(2):137-46. PubMed ID: 12203760 [TBL] [Abstract][Full Text] [Related]
16. Dynamic susceptibility contrast perfusion imaging of radiation effects in normal-appearing brain tissue: changes in the first-pass and recirculation phases. Lee MC; Cha S; Chang SM; Nelson SJ J Magn Reson Imaging; 2005 Jun; 21(6):683-93. PubMed ID: 15906330 [TBL] [Abstract][Full Text] [Related]
17. Effects of scopolamine challenge on regional cerebral blood volume. A pharmacological model to validate the use of contrast enhanced magnetic resonance imaging to assess cerebral blood volume in a canine model of aging. Tapp PD; Chu Y; Araujo JA; Chiou JY; Head E; Milgram NW; Su MY Prog Neuropsychopharmacol Biol Psychiatry; 2005 Mar; 29(3):399-406. PubMed ID: 15795048 [TBL] [Abstract][Full Text] [Related]
18. Experimental estimates of the constants relating signal change to contrast concentration for cerebral blood volume by T2* MRI. Newman GC; Hospod FE; Patlak CS; Fain SE; Pulfer KA; Cook TD; O'Sullivan F J Cereb Blood Flow Metab; 2006 Jun; 26(6):760-70. PubMed ID: 16319833 [TBL] [Abstract][Full Text] [Related]